Business Context and Reporting Period
This Form 8-K, dated November 7, 2024, serves as a supplemental disclosure to the Definitive Proxy Statement regarding the proposed merger between Bally's Corporation ("Bally's") and Standard General L.P. ("Standard General"). The filing addresses shareholder lawsuits and demand letters alleging deficiencies in the proxy materials. Bally's voluntarily supplemented the disclosures to mitigate litigation risks without admitting liability. A special meeting of stockholders is scheduled for November 19, 2024, to vote on the Merger Agreement.
Key Financial Metrics and Transaction Terms
The filing does not report standard operating metrics such as revenue, profit, or cash flow for a specific reporting period. Instead, it details financial parameters related to the proposed acquisition and valuation analyses:
- Offer Price: $15.00 per share (representing a 41% premium to the March 8, 2024 closing price).
- Financial Advisor Fees: Bally's agreed to pay Macquarie Capital an aggregate fee of $10.6 million ($300,000 engagement fee, $1.0 million opinion fee, and $9.3 million contingent on consummation).
- Valuation Multiples (2024E): Selected public companies adjusted EBITDAR multiples range of 7.6x to 8.2x.
- Valuation Multiples (2025E): Selected public companies adjusted EBITDAR multiples range of 6.4x to 7.5x.
- Precedent Transactions: Latest 12 months adjusted EBITDAR multiples range of 7.8x to 8.8x.
- Discounted Cash Flow (DCF): Discount rates of 10.7% to 12.7%; perpetuity growth rates of 1.5% to 2.5%; terminal value multiples of 7.5x to 8.5x.
- Analyst Price Targets: As of the unaffected date, the mean target was $11.43 and the median was $11.00.
Material Changes and Supplemental Disclosures
The filing amends the Definitive Proxy Statement with the following specific clarifications:
- Initial Proposal Details: Clarified that Standard General's March 2024 proposal did not reference the role of management post-closing and required approval by a special committee and a majority of shares not owned by Standard General.
- Confidentiality Agreements: Confirmed that confidentiality agreements with Standard General and "Party M" (Macquarie Capital) included 12-month standstill provisions but explicitly did not contain "Don't Ask, Don't Waive" provisions.
- Valuation Methodology: Provided specific ranges for multiples, growth rates, and discount rates used by Macquarie Capital in their financial analyses, emphasizing that no single company or transaction was identical to Bally's.
- Land Valuation: Clarified the price per acre range ($10 million to $15 million) applied to the Tropicana Las Vegas property, excluding land committed to the Oakland Athletics stadium.
Guidance, Risks, and Contingencies
Management Commentary: The Board continues to recommend a "FOR" vote on the Merger Agreement. The company asserts the lawsuits are without merit and that the proxy statements comply with applicable law.
Risks and Contingencies:
- Litigation: Two lawsuits filed in New York Supreme Court (Nathan Smith v. Bally's and Robert Scott v. Bally's) seek to enjoin the merger or award rescissory damages.
- Transaction Risks: Risks include failure to obtain regulatory approvals, financing, or stockholder approval; disruption of management attention; and general market volatility.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from projections due to factors such as geopolitical crises, pandemics, and economic conditions.
Investor Verification Checklist
- Verify the specific terms of the "Don't Ask, Don't Waive" provisions (or lack thereof) in the confidentiality agreements with Standard General and Party M.
- Review the full Definitive Proxy Statement and Schedule 13E-3 for complete details on the $15.00 per share offer and rollover election options.
- Monitor the status of the two pending shareholder lawsuits in the Supreme Court of the State of New York for potential injunctions.
- Confirm the final vote count at the Special Meeting on November 19, 2024, to ensure the merger receives the required stockholder approval.
- Assess the $10.6 million advisory fee structure and its impact on transaction costs relative to the deal value.